566 related articles for article (PubMed ID: 12021526)
1. Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH.
Coen G; Ballanti P; Bonucci E; Calabria S; Costantini S; Ferrannini M; Giustini M; Giordano R; Nicolai G; Manni M; Sardella D; Taggi F
Nephron; 2002 May; 91(1):103-11. PubMed ID: 12021526
[TBL] [Abstract][Full Text] [Related]
2. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.
Coen G; Ballanti P; Bonucci E; Calabria S; Centorrino M; Fassino V; Manni M; Mantella D; Mazzaferro S; Napoletano I; Sardella D; Taggi F
Nephrol Dial Transplant; 1998 Sep; 13(9):2294-302. PubMed ID: 9761512
[TBL] [Abstract][Full Text] [Related]
3. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients.
Bervoets AR; Spasovski GB; Behets GJ; Dams G; Polenakovic MH; Zafirovska K; Van Hoof VO; De Broe ME; D'Haese PC
Am J Kidney Dis; 2003 May; 41(5):997-1007. PubMed ID: 12722034
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: an observational retrospective cohort study.
De Paola L; Coppolino G; Bolignano D; Buemi M; Lombardi L
Ther Apher Dial; 2010 Dec; 14(6):566-71. PubMed ID: 21118364
[TBL] [Abstract][Full Text] [Related]
5. Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis.
Hernandez D; Concepcion MT; Lorenzo V; Martinez ME; Rodriguez A; De Bonis E; Gonzalez-Posada JM; Felsenfeld AJ; Rodriguez M; Torres A
Nephrol Dial Transplant; 1994; 9(5):517-23. PubMed ID: 7522307
[TBL] [Abstract][Full Text] [Related]
6. Histomorphometric assessment of bone turnover in uraemic patients: comparison between activation frequency and bone formation rate.
Ballanti P; Coen G; Mazzaferro S; Taggi F; Giustini M; Calabria S; Ferrannini M; Bonucci E
Histopathology; 2001 Jun; 38(6):571-83. PubMed ID: 11422502
[TBL] [Abstract][Full Text] [Related]
7. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels.
Gal-Moscovici A; Popovtzer MM
Clin Nephrol; 2005 Apr; 63(4):284-9. PubMed ID: 15847255
[TBL] [Abstract][Full Text] [Related]
8. PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease.
Coen G; Bonucci E; Ballanti P; Balducci A; Calabria S; Nicolai GA; Fischer MS; Lifrieri F; Manni M; Morosetti M; Moscaritolo E; Sardella D
Am J Kidney Dis; 2002 Aug; 40(2):348-54. PubMed ID: 12148108
[TBL] [Abstract][Full Text] [Related]
9. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
Cantor T; Sci B
Nefrologia; 2003; 23 Suppl 2():69-72. PubMed ID: 12778858
[TBL] [Abstract][Full Text] [Related]
10. Renal osteodystrophy in dialysis patients: diagnosis and treatment.
Fournier A; Oprisiu R; Hottelart C; Yverneau PH; Ghazali A; Atik A; Hedri H; Said S; Sechet A; Rasolombololona M; Abighanem O; Sarraj A; El Esper N; Moriniere P; Boudailliez B; Westeel PF; Achard JM; Pruna A
Artif Organs; 1998 Jul; 22(7):530-57. PubMed ID: 9684690
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
[TBL] [Abstract][Full Text] [Related]
12. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
[TBL] [Abstract][Full Text] [Related]
13. [Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers].
Jarava C; Armas JR; Palma A
Nefrologia; 2000; 20(4):362-72. PubMed ID: 11039262
[TBL] [Abstract][Full Text] [Related]
14. Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study.
Coen G; Mazzaferro S; Ballanti P; Sardella D; Chicca S; Manni M; Bonucci E; Taggi F
Nephrol Dial Transplant; 1996 May; 11(5):813-9. PubMed ID: 8671900
[TBL] [Abstract][Full Text] [Related]
15. Serum osteoprotegerin and renal osteodystrophy.
Coen G; Ballanti P; Balducci A; Calabria S; Fischer MS; Jankovic L; Manni M; Morosetti M; Moscaritolo E; Sardella D; Bonucci E
Nephrol Dial Transplant; 2002 Feb; 17(2):233-8. PubMed ID: 11812872
[TBL] [Abstract][Full Text] [Related]
16. Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients.
Moore C; Yee J; Malluche H; Rao DS; Monier-Faugere MC; Adams E; Daramola-Ogunwuyi O; Fehmi H; Bhat S; Osman-Malik Y
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1484-1493. PubMed ID: 19713297
[TBL] [Abstract][Full Text] [Related]
17. Two-site immunoradiometric intact parathyroid hormone assay versus C-terminal parathyroid hormone in predicting osteodystrophic bone lesions in predialysis chronic renal failure.
Coen G; Mazzaferro S; Ballanti P; Bonucci E; Cinotti GA; Fondi G; Manni M; Pasquali M; Perruzza I; Sardella D
J Lab Clin Med; 1993 Jul; 122(1):103-9. PubMed ID: 8320484
[TBL] [Abstract][Full Text] [Related]
18. Imaging of bone in the diagnostics of renal osteodystrophy in children with chronic renal failure.
Ziółkowska H; Pańczyk-Tomaszewska M; Majkowska Z; Rajkowski T; Debiński A; Przedlacki J; Sawicki A; Ostrowski K; Marciński A; Roszkowska-Blaim M
Med Sci Monit; 2001; 7(5):1034-42. PubMed ID: 11535955
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis.
Qi Q; Monier-Faugere MC; Geng Z; Malluche HH
Am J Kidney Dis; 1995 Oct; 26(4):622-31. PubMed ID: 7573017
[TBL] [Abstract][Full Text] [Related]
20. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.
Coen G; Ballanti P; Balducci A; Grandi F; Manni M; Mantella D; Pierantozzi A; Ruggeri M; Sardella D; Sorbo G; Bonucci E
Am J Kidney Dis; 2006 Jul; 48(1):106-13. PubMed ID: 16797392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
